Alterations in the Smad pathway in human cancers.

Academic Article

Abstract

  • Members of the TGF-beta superfamily exhibit various biological activities, and perturbations of their signaling are linked to certain clinical disorders including cancer. The role of TGF-beta signaling as a tumor suppressor pathway is best illustrated by the presence of inactivating mutations in genes encoding TGF-beta receptors and Smads in human carcinomas. This perspective is further supported by studies of tumor development in mouse models after modulation of receptors and Smads. TGF-beta also controls processes such as cell invasion, immune regulation, and microenvironment alterations that cancer cells may exploit to their advantage for their progression. Consequently, the output of a TGF-beta response is highly situation dependent, across different tissues, and also in cancer in general. Understanding the mechanisms of TGF-beta superfamily signaling is thus important for the development of new ways to treat various types of cancer. This review focuses on recent advances in understanding the Smad dependent TGF-beta pathway as it relates to human carcinogenesis.
  • Published In

    Keywords

  • Animals, Humans, Mice, Models, Molecular, Neoplasms, Smad Proteins, Transforming Growth Factor beta, Up-Regulation
  • Author List

  • Samanta D; Datta PK
  • Start Page

  • 1281
  • End Page

  • 1293
  • Volume

  • 17